NYVEPRIA 6 mg, solution for injection syringe, 0.6 ml
Active ingredients: Pegfilgrastim
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.6 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NYVEPRIA 6 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,6 ml avec aiguille(s) acier inoxydable avec protège-aiguille
- Marketing authorisation holder
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68698437CIP73021627CIP133400930216279Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PEGFILGRASTIMsolution | 6 mg · une seringue préremplie de 0,6 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.